Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-11
SponsorEgyptian Chinese University
About this trial
This is an observational study that aims to understand the effects of passive smoking (secondhand smoke exposure) on children's health and development. The main question the study seeks to answer is:
How does exposure to secondhand smoke affect the physical fitness, cognitive abilities, and academic performance of primary school children?
The study will compare two groups of children aged 6-11 years: one group exposed to secondhand smoke at home (due to parents or caregivers who smoke) and another group not exposed to secondhand smoke. The children's physical capacity, cognitive skills, and school performance will be assessed through various tests.
The goal of the study is to provide valuable insights into how secondhand smoke may negatively impact children, helping families, schools, and healthcare providers understand the risks and promote healthier, smoke-free environments for children.
Eligibility criteria
Qualifiers
Children aged 6-11 years, enrolled in primary school.
Both genders (male and female).
Healthy children with no musculoskeletal, visual, auditory, or cognitive impairments.
Children whose parents have been smoking for at least 6 years, with moderate to high smoking levels (based on the smoking index).
Disqualifiers
Children with musculoskeletal problems, congenital deformities, visual or auditory defects, learning disabilities, or autism.
Children who are currently taking medications that affect alertness or cognitive function.
Children who are not exposed to secondhand smoke (non-smokers) but have parents who smoke at very low levels or do not meet the inclusion criteria for passive smoking exposure.
Children who are unable to cooperate or participate in the assessments.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
90 Participants
are grouped into 2 trial groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov